MARRONE BIO INNOVATIONS, INC. (MBII) Files An 8-K Results of Operations and Financial Condition
Item2.02.
|
Results of Operations and Financial Condition. |
On November 14, 2016, Marrone Bio Innovations, Inc. (the Company)
issued a press release announcing, and will hold a press
conference regarding, its results of operations for the fiscal
quarter ended September 30, 2016. A copy of the press release is
furnished as Exhibit 99.1 to this report.
The information furnished to this Item 2.02, including Exhibit
99.1, shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities under that section and
shall not be deemed to be incorporated by reference into any
filing of the Company under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set
forth by specific reference in such filing.
| Item9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
|
Exhibit No. |
Description |
|
| 99.1 |
Press release issued on November 14, 2016 by Marrone Bio Innovations, Inc. |
About MARRONE BIO INNOVATIONS, INC. (MBII)
